Screener
ClearPoint Neuro CLPT Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by ClearPoint Neuro in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: ClearPoint Neuro’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221890
| Line item | March 31, 2026 / (Unaudited) | December 31, 2025 |
|---|---|---|
| Long-term notes payable, net | 49,644 | 49,077 |
| Deferred tax liabilities, net | 354 | 354 |
| Other long-term liabilities | 779 | 489 |
| Total liabilities | 74,575 | 69,727 |
| Commitments and contingencies | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.01 par value; 25,000,000 shares authorized; none issued and outstanding at March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.01 par value; 90,000,000 shares authorized at March 31, 2026 and December 31, 2025; 29,986,639 and 29,368,760 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 300 | 294 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is ClearPoint Neuro's total liabilities?
- ClearPoint Neuro (CLPT) reported total liabilities of $74.58M in Q1 2026.
- How has ClearPoint Neuro's total liabilities changed year-over-year?
- ClearPoint Neuro's total liabilities increased by 639.6% year-over-year, from $10.08M to $74.58M.
- What is the long-term trend for ClearPoint Neuro's total liabilities?
- Over 5 years (2020 to 2025), ClearPoint Neuro's total liabilities has grown at a 20.8% compound annual growth rate (CAGR), from $27.14M to $69.73M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about ClearPoint Neuro's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude